glp 1 agonists on the market GLP-1 Receptor Agonist Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 GLP-1 Receptor Agonist Market Forecast

In a study, 8 out of 10 men with psychogenic erectile dysfunction, who were able to achieve erections while sleeping, but unable to do so before sexual activity, treated with Melanotan II developed penile erections [6]

Until then, experts are generally skeptical that GLP-1 RAs are a good idea for athletes who dont medically need them

Second, semaglutide has been shown to be ineffective in patients with compensated MASH-related cirrhosis 10

And theres a concern among many clinicians that, because BPC-157 seems to influence growth-related pathways, theres a theoretical risk it could spur tumor growth if cancer cells are present